A diagnostic test from Abbott provides information used for CF carrier screening, newborn screening and confirmation of CF diagnoses in newborns and children.
The Cystic Fibrosis Genotyping Assay looks for and examines mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in human DNA. The panel includes mutations and variants recommended by the American College of Medical Genetics and the American College of Obstetricians and Gynecologists, plus additional mutiethnic mutations.
According to Abbott, the Cystic Fibrosis Genotyping Assay provides information intended to be used for carrier screening in adults of reproductive age, as an aid in newborn screening, and in confirmatory diagnostic testing in newborns and children. The test is not indicated for use in fetal diagnostic or pre-implantation testing. This test is also not indicated for stand-alone diagnostic purposes.
For more information, please visit the Abbott Molecular website.
Source: Abbott